Search research articles
Contact Us
Filters
Showing results (291-300 of 393) with videos related to
Page
of 40
Sort By:
Human Pathology
|
June 29, 2000
Progression to invasive melanoma from malignant melanoma in situ, lentigo maligna type
Z S Tannous, L H Lerner, L M Duncan, et al.
Endocrinology
|
July 5, 2005
Stimulation of resorption in cultured mouse calvarial bones by thiazolidinediones
A M Schwab, S Granholm, E Persson, et al.
Bone
|
April 25, 2000
A peptidyl derivative structurally based on the inhibitory center of cystatin C inhibits bone resorption in vitro
L Johansson, A Grubb, M Abrahamson, et al.
Endocrinology
|
January 6, 2001
Vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide receptor subtypes in mouse calvarial osteoblasts: presence of VIP-2 receptors and differentiation-induced expression of VIP-1 receptors
P Lundberg, I Lundgren, H Mukohyama, et al.
Acta Physiologica Scandinavica
|
October 6, 1997
Cystatin C, and inhibitor of bone resorption produced by osteoblasts
U H Lerner, L Johansson, M Ranjsö, et al.
Diseases of the Colon and Rectum
|
May 1, 1986
A comparison of stapled and handsewn anastomoses in patients undergoing resection for Dukes' B and C colorectal cancer. An analysis of disease-free survival and survival from the NSABP prospective clinical trials
N Wolmark, P H Gordon, B Fisher, et al.
Bone
|
July 12, 2002
Characterization of the bone-resorptive effect of interleukin-11 in cultured mouse calvarial bones
J Ahlen, S Andersson, H Mukohyama, et al.
Acta Endocrinologica
|
August 1, 1993
Parathyroid hormone is able to enhance cyclic adenosine monophosphate formation without causing an increase in cytoplasmic Ca2+ in osteoblasts
O Ljunggren, H Johansson, P Ridefelt, et al.
Cytokine
|
April 5, 2005
Cytokine responses of human gingival fibroblasts to Actinobacillus actinomycetemcomitans cytolethal distending toxin
G N Belibasakis, A Johansson, Y Wang, et al.
Cancer
|
September 1, 1982
Failure of effective initial chemotherapy to modify the course of stage IV (MO) squamous cancer of the head and neck
S E Vogl, H Lerner, B H Kaplan, et al.
Page
of 40
Search research articles
Search
Showing results (291-300 of 393) with videos related to
Sort By:
Page
of 40
Human Pathology
|
June 29, 2000
Progression to invasive melanoma from malignant melanoma in situ, lentigo maligna type
Z S Tannous, L H Lerner, L M Duncan, et al.
Endocrinology
|
July 5, 2005
Stimulation of resorption in cultured mouse calvarial bones by thiazolidinediones
A M Schwab, S Granholm, E Persson, et al.
Bone
|
April 25, 2000
A peptidyl derivative structurally based on the inhibitory center of cystatin C inhibits bone resorption in vitro
L Johansson, A Grubb, M Abrahamson, et al.
Endocrinology
|
January 6, 2001
Vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide receptor subtypes in mouse calvarial osteoblasts: presence of VIP-2 receptors and differentiation-induced expression of VIP-1 receptors
P Lundberg, I Lundgren, H Mukohyama, et al.
Acta Physiologica Scandinavica
|
October 6, 1997
Cystatin C, and inhibitor of bone resorption produced by osteoblasts
U H Lerner, L Johansson, M Ranjsö, et al.
Diseases of the Colon and Rectum
|
May 1, 1986
A comparison of stapled and handsewn anastomoses in patients undergoing resection for Dukes' B and C colorectal cancer. An analysis of disease-free survival and survival from the NSABP prospective clinical trials
N Wolmark, P H Gordon, B Fisher, et al.
Bone
|
July 12, 2002
Characterization of the bone-resorptive effect of interleukin-11 in cultured mouse calvarial bones
J Ahlen, S Andersson, H Mukohyama, et al.
Acta Endocrinologica
|
August 1, 1993
Parathyroid hormone is able to enhance cyclic adenosine monophosphate formation without causing an increase in cytoplasmic Ca2+ in osteoblasts
O Ljunggren, H Johansson, P Ridefelt, et al.
Cytokine
|
April 5, 2005
Cytokine responses of human gingival fibroblasts to Actinobacillus actinomycetemcomitans cytolethal distending toxin
G N Belibasakis, A Johansson, Y Wang, et al.
Cancer
|
September 1, 1982
Failure of effective initial chemotherapy to modify the course of stage IV (MO) squamous cancer of the head and neck
S E Vogl, H Lerner, B H Kaplan, et al.
Page
of 40